Clinical Trial: A Study to Evaluate the Drug Interactions of HRS-7535 With Acetaminophen, Digoxin, Rosuvastatin, and Omeprazole in Obese or Overweight Subjects

U.S., Dec. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07269756) titled 'A Study to Evaluate the Drug Interactions of HRS-7535 With Acetaminophen, Digoxin, Rosuvastatin, and Omeprazole in Obese or Overweight Subjects' on Nov. 26.

Brief Summary: This study is an open-label, fixed-sequence, self-controlled Phase I clinical trial conducted among obese or overweight subjects, with a planned enrollment of 40 adult subjects.

Study Start Date: Dec., 2025

Study Type: INTERVENTIONAL

Condition: Obesity Overweight

Intervention: DRUG: HRS-7535 Tablets

HRS-7535 tablet.

DRUG: Paracetamol Tablets

Paracetamol tablet.

DRUG: Digoxin Tablets

Digoxin tablet.

DRUG: Rosuvastatin Calcium Tablets

Rosuvastatin Calciu...